Related Experiment Videos
Long-term results of operations for mitral insufficiency secondary to coronary artery disease
Insights
Mitral valve repair offers superior long-term survival rates compared to mitral valve replacement in patients with coronary artery disease and mitral insufficiency. Proper repair techniques are crucial for better outcomes.
Area of Science:
- Cardiology
- Cardiac Surgery
- Cardiovascular Research
Background:
- Significant mitral insufficiency is a complication of coronary artery disease.
- Limited data exists on long-term outcomes for surgical treatment of this condition.
- Current approaches often involve mitral valve replacement or myocardial revascularization.
Purpose of the Study:
- To compare the long-term results of mitral valve repair versus mitral valve replacement in patients with coronary artery disease and mitral insufficiency.
- To evaluate the efficacy of mitral repair in conjunction with myocardial revascularization.
Main Methods:
- Retrospective analysis of 87 patients undergoing surgery for mitral insufficiency secondary to coronary artery disease.
- Patients' ejection fractions ranged from 0.1 to normal.
- Surgical interventions included mitral valve replacement (16 patients) and mitral valve repair (71 patients), alongside myocardial revascularization.
Main Results:
- Overall 9-year survival rate was 60% for the entire cohort.
- Patients undergoing mitral valve replacement and revascularization had an 18% survival rate at 9 years.
- Patients undergoing mitral valve repair and revascularization demonstrated a significantly higher 9-year survival rate of 73%.
Conclusions:
- Mitral valve repair, when performed correctly, is superior to mitral valve replacement for managing mitral insufficiency in the context of coronary artery disease.
- The findings support a preference for mitral repair over replacement in this patient population.
- Surgical technique and approach significantly impact long-term patient survival.
Abstract:
There are few published reports regarding the long-term results of the operative treatment of significant mitral insufficiency secondary to coronary artery disease. The few available reports deal with mitral replacement and myocardial revascularization. However, we prefer mitral repair to mitral replacement with myocardial revascularization. Eighty-seven patients were operated upon with ejection fractions between 0.1 and normal. In 16 patients it was necessary to replace the mitral valve; however, the valve was repaired in the remaining 71 patients. By actuarial curve the survival rate at 9 years was 60 percent for the entire series, and 18 percent in the 16 patients with mitral valve replacement and revascularization. This contrasted with a 73 percent survival rate for those patients with repair of the mitral valve and revascularization. We feel strongly that if repair is done properly, it is far superior to mitral valve replacement for the patient with mitral insufficiency secondary to coronary artery disease.